News
9 November 2022
The XIV meeting of the Spanish Drug Discovery Network (SDDN) will take place in Granada, Spain, on November 24 and 25, 2022. This international conference has […]
7 November 2022
Cannabinoid receptors, CB1 and CB2 are two extensively studied targets of the GPCR family for the treatment of numerous conditions, including inflammatory diseases, autoimmune disorders, pain, […]
26 October 2022
G-protein coupled receptors (GPCRs) have been targeted mainly in a wide range of diseases. Still, few therapies have been directed against GPCRs in the field of cancer, […]
20 September 2022
To date, it has been reported that about 800 GPCRs are encoded by the human genome. Some of them have known ligands available which led to the […]
26 July 2022
The ONCOMET group from the Health Research Institute of Santiago led by Dr. Miguel Abal has published an interesting article showing tumor and stromal-specific genetic signatures […]
15 July 2022
We are proud to announce our new collaboration with the marketplace company Chemspace for the distribution of our exclusive GPCR fluorescent probes. Chemspace is the largest […]
6 April 2022
The glucagon-like peptide-1 receptor (GLP1R), expressed in peripheral tissues and brain, is known to be involved in several metabolic and inflammatory processes. Despite its clear interest […]
21 February 2022
From February 5th to 9th our CEO Sonia Martínez Arca has attended the international SLAS, (Society for Laboratory Automation and Screening), meeting at Boston. Celtarys Research […]
3 February 2022
The group led by Dr. Eddy Sotelo at the University of Santiago de Compostela, in collaboration with the Uppsala University, has published a new article exploring […]